Search research articles
Contact Us
Filters
Showing results (51-60 of 171) with videos related to
Page
of 18
Sort By:
Clinical Chemistry
|
September 1, 2023
Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
International Journal of Molecular Sciences
|
December 23, 2023
Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
Maturitas
|
October 22, 2021
Cross-sectional and longitudinal interaction effects of physical activity and APOE-ε4 on white matter integrity in older adults: The MAPT study
Jérémy Raffin, Yves Rolland, Lingxiao He, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 3, 2023
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 16, 2014
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly
Audrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, et al.
The Journal of Prevention of Alzheimer'S Disease
|
April 20, 2025
A six-year risk assessment for dementia and Alzheimer's disease in the general population through immunoprecipitation-mass spectrometry plasma amyloid quantification
Germain U Busto, Christophe Hirtz, Isabelle Carriere, et al.
Journal of Personalized Medicine
|
November 27, 2021
Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort
Esteban Munoz Musat, Emeline Marlinge, Mélanie Leroy, et al.
Journal of Proteome Research
|
January 9, 2016
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
Nicolas R Barthélemy, François Fenaille, Christophe Hirtz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 31, 2016
Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios
Cecilia Marelli, Laure-Anne Gutierrez, Nicolas Menjot de Champfleur, et al.
Journal of Alzheimer'S Disease : JAD
|
March 1, 2016
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
Nicolas R Barthélemy, Audrey Gabelle, Christophe Hirtz, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 171) with videos related to
Sort By:
Page
of 18
Clinical Chemistry
|
September 1, 2023
Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
International Journal of Molecular Sciences
|
December 23, 2023
Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
Maturitas
|
October 22, 2021
Cross-sectional and longitudinal interaction effects of physical activity and APOE-ε4 on white matter integrity in older adults: The MAPT study
Jérémy Raffin, Yves Rolland, Lingxiao He, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 3, 2023
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 16, 2014
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly
Audrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, et al.
The Journal of Prevention of Alzheimer'S Disease
|
April 20, 2025
A six-year risk assessment for dementia and Alzheimer's disease in the general population through immunoprecipitation-mass spectrometry plasma amyloid quantification
Germain U Busto, Christophe Hirtz, Isabelle Carriere, et al.
Journal of Personalized Medicine
|
November 27, 2021
Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort
Esteban Munoz Musat, Emeline Marlinge, Mélanie Leroy, et al.
Journal of Proteome Research
|
January 9, 2016
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
Nicolas R Barthélemy, François Fenaille, Christophe Hirtz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 31, 2016
Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios
Cecilia Marelli, Laure-Anne Gutierrez, Nicolas Menjot de Champfleur, et al.
Journal of Alzheimer'S Disease : JAD
|
March 1, 2016
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
Nicolas R Barthélemy, Audrey Gabelle, Christophe Hirtz, et al.
Page
of 18